Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SOLIGENIX, INC.SNGX · Entity 8067 | CMO (Consulting) | December 11, 2025 | December 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SOLIGENIX, INC.
Report date December 11, 2025 · Filed December 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.63 · Expires 2035-12-10 | Direct | 10,000 |
Reported balance
After 2025-12-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-11 · Grant · Acquired 10,000 · Balance 10,000 F1: The stock option vested immediately as to 25% of the shares and vests as to the remaining 75% of the shares in 12 equal installments (or nearly equal installments if the number of remaining shares is not evenly divisible by 12) on each three (3) month anniversary of December 11, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option vested immediately as to 25% of the shares and vests as to the remaining 75% of the shares in 12 equal installments (or nearly equal installments if the number of remaining shares is not evenly divisible by 12) on each three (3) month anniversary of December 11, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 11, 2025 Filed Dec 12, 2025 21:18 UTC | SOLIGENIX, INC. SNGX · Entity 8067 | GrantOption (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0001595197-25-000003 · form4-12122025_091227.xml · derivative · entry 1 Straube Richard · CIK 0001595197 · CMO (Consulting) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2035-12-10 F1 · security: The stock option vested immediately as to 25% of the shares and vests as to the remaining 75% of the shares in 12 equal installments (or nearly equal installments if the number of remaining shares is not evenly divisible by 12) on each three (3) month anniversary of December 11, 2025. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:25 UTC | SOLIGENIX, INC. SNGX · Entity 8067 | GrantOption (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $3.31 | $0.00 |
DisclosureSEC source: 0001415889-24-029305 · form4-12132024_091237.xml · derivative · entry 1 Straube Richard · CIK 0001595197 · SENIOR VICE PRESIDENT AND CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2034-12-11 F1 · security: The stock option vested immediately as to 25% of the shares and vests as to the remaining 75% of the shares in 12 equal installments (or nearly equal installments if the number of remaining shares is not evenly divisible by 12) on each three (3) month anniversary of December 12, 2024. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 22:11 UTC | SOLIGENIX, INC. SNGX · Entity 8067 | GrantOption (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0001415889-23-016089 · form4-12082023_101231.xml · derivative · entry 1 Straube Richard · CIK 0001595197 · SENIOR VICE PRESIDENT AND CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-12-07 F1 · security: The stock option vested immediately as to 25% of the shares and vests as to the remaining 75% of the shares in 12 equal installments (or nearly equal installments if the number of remaining shares is not evenly divisible by 12) on each three (3) month anniversary of December 8, 2023. Read SEC document |
| December 08, 2022 Filed Dec 9, 2022 21:09 UTC | SOLIGENIX, INC. SNGX · Entity 8067 | GrantOption (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001415889-22-012305 · form4-12092022_091230.xml · derivative · entry 1 Straube Richard · CIK 0001595197 · SENIOR VICE PRESIDENT AND CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2032-12-07 F1 · security: The stock option vested immediately as to 20,000 shares and vests as to the remainder at a rate of 5,000 of the shares on each three (3) month anniversary of December 8, 2022. Read SEC document |
| May 18, 2022 Filed May 18, 2022 22:02 UTC | SOLIGENIX, INC. SNGX · Entity 8067 | PurchaseCOMMON STOCK | 8,000 | $0.50 | $4,000.00 |
DisclosureSEC source: 0001415889-22-005252 · form4-05182022_030516.xml · nonDerivative · entry 1 Straube Richard · CIK 0001595197 · SENIOR VICE PRESIDENT AND CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 21:01 UTC | SOLIGENIX, INC. SNGX · Entity 8067 | GrantOption (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001104659-21-148558 · tm2135164-1_4seq1.xml · derivative · entry 1 Straube Richard · CIK 0001595197 · CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-12-08 F1 · security: The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 9, 2021. F1 · derivative.exercise_date: The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 9, 2021. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 22:05 UTC | SOLIGENIX, INC. SNGX · Entity 8067 | GrantOption (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.34 | $0.00 |
DisclosureSEC source: 0001213900-20-042291 · ownership.xml · derivative · entry 1 Straube Richard · CIK 0001595197 · CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2030-12-09 F1 · security: The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 10,2020. F1 · derivative.exercise_date: The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 10,2020. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:31 UTC | SOLIGENIX, INC. SNGX · Entity 8067 | GrantOption (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001213900-19-026154 · ownership.xml · derivative · entry 1 Straube Richard · CIK 0001595197 · SVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-12-11 F1 · security: The stock option vested immediately as to 7,500 shares and vests as to the remainder at a rate of 1,875 of the shares on each three (3) month anniversary of December 12, 2019. F1 · derivative.exercise_date: The stock option vested immediately as to 7,500 shares and vests as to the remainder at a rate of 1,875 of the shares on each three (3) month anniversary of December 12, 2019. Read SEC document |
| December 13, 2018 Filed Dec 14, 2018 21:34 UTC | SOLIGENIX, INC. SNGX · Entity 8067 | GrantOption (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.97 | $0.00 |
DisclosureSEC source: 0001213900-18-017382 · ownership.xml · derivative · entry 1 Straube Richard · CIK 0001595197 · SVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-12-12 F1 · security: The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 13, 2018. F1 · derivative.exercise_date: The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 13, 2018. Read SEC document |
| December 07, 2017 Filed Dec 11, 2017 21:18 UTC | SOLIGENIX, INC. SNGX · Entity 8067 | GrantOption (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001213900-17-013093 · f4120717straube_soligenix.xml · derivative · entry 1 Straube Richard · CIK 0001595197 · SVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2027-12-06 F1 · security: The stock option vested immediately as to 8,750 shares and vests as to the remainder at a rate of 2,187.5 of the shares on each three (3) month anniversary of December 7, 2017. F1 · derivative.exercise_date: The stock option vested immediately as to 8,750 shares and vests as to the remainder at a rate of 2,187.5 of the shares on each three (3) month anniversary of December 7, 2017. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 20:17 UTC | SOLIGENIX, INC. SNGX · Entity 8067 | GrantOption (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.67 | $0.00 |
DisclosureSEC source: 0001213900-17-003325 · f4033117straube_soligenix.xml · derivative · entry 1 Straube Richard · CIK 0001595197 · SVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-03-30 F1 · security: The stock option vested immediately as to 5,000 shares and vests as to the remainder at a rate of 1,250 of the shares on each three (3) month anniversary of March 31, 2017. F1 · derivative.exercise_date: The stock option vested immediately as to 5,000 shares and vests as to the remainder at a rate of 1,250 of the shares on each three (3) month anniversary of March 31, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.